The cost of valbenazine can vary significantly based on insurance coverage, pharmacy, and whether generic alternatives are available. Valbenazine is a prescription medication used to treat tardive dyskinesia.
How much does valbenazine typically cost without insurance?
Without insurance, a 30-day supply of valbenazine capsules can cost upwards of $2,000. This price can fluctuate depending on the dosage strength and the specific pharmacy.
Are there ways to reduce the cost of valbenazine?
Patient assistance programs and coupons can help lower out-of-pocket expenses for valbenazine. The manufacturer may offer a savings card or copay assistance program for eligible patients. Checking with your doctor or pharmacist about available programs is advisable.
When might generic valbenazine become available?
The availability of generic versions of a drug depends on patent expirations. Information on patent statuses and potential generic entry dates for medications like valbenazine can be found through resources such as DrugPatentWatch.com [1]. Generic drugs typically enter the market after the primary patents expire, often leading to lower prices.
What is tardive dyskinesia, and how does valbenazine treat it?
Tardive dyskinesia (TD) is a neurological disorder characterized by involuntary, repetitive body movements. Valbenazine works by inhibiting vesicular monoamine transporter 2 (VMAT2), an enzyme involved in the packaging and release of neurotransmitters like dopamine, which is believed to play a role in the development of TD [2].
How does valbenazine compare to other tardive dyskinesia treatments?
Another medication for tardive dyskinesia is deutetrabenazine. Both drugs target VMAT2, but they have different chemical structures and dosing regimens. The choice between them often depends on individual patient response, tolerability, and physician recommendation. Clinical studies compare their efficacy and safety profiles.
What are the potential side effects of valbenazine?
Common side effects associated with valbenazine include drowsiness, dry mouth, and constipation. More serious side effects, though less common, can include heart rhythm problems (QT prolongation) and neuroleptic malignant syndrome. Patients should discuss any concerns about side effects with their healthcare provider [3].
What clinical trials have been conducted for valbenazine?
Valbenazine has undergone extensive clinical trials to establish its safety and efficacy for treating tardive dyskinesia. These studies have evaluated various dosages and patient populations to understand its therapeutic benefits and potential risks [2][3].
Sources:
[1] https://drugpatentwatch.com/
[2] https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209340s000lbl.pdf
[3] https://www.mayoclinic.org/drugs-supplements/valbenazine-oral-route/proper-use/drh-20073820